Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“Honored to be chairing this ASH24 session on bispecific antibody immunotherapy for lymphoma on behalf of Krish Patel, Sarah Cannon Docs, Lorna Warwick, and our Mount Sinai NYC team!”
